Nigeria to launch pilot cancer drug access program

18 September 2018
nigeria-big

The Federal Ministry of Health of Nigeria and BIO Ventures for Global Health (BVGH), a non-profit organization, convened a Cancer Stakeholder meeting last week under the auspices of BVGH’s Africa Access Initiative (AAI) to finalize plans for a pilot cancer drug access program to combat Nigeria’s rapidly rising cancer burden.

The Ministry will be issuing a Request for Proposals (RFP) to pharmaceutical companies to kick-start the program.

“As Nigeria’s Minister of Health and an oncologist, I have personally witnessed the devastation that cancer has caused our citizens, and I will marshal all the resources of my office to prevent further needless suffering and death,” said Minister of Health, Professor Isaac Adewole, adding: “Collaborating with BVGH and leading academic and industry partners, including Memorial Sloan Kettering Cancer Center, Pfizer, and Takeda, is critical for saving Nigerian cancer patients’ lives.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical